Criteria Bio Ventures
Venture capitalBarcelona · Seed–Late Stage · 8 people tracked
Investment thesis
Criteria Bio Ventures partners long-term with entrepreneurs and co-investors developing disruptive, well-protected innovations in healthcare that address significant unmet medical needs. The fund invests in private biotech companies across Europe and North America, with a special focus on Spain and Portugal. It takes a modality- and disease-agnostic approach, backing therapies across a wide range of areas, and offers evergreen support until meaningful impact is achieved. The firm frequently acts as a cornerstone or early investor, helping companies advance from academia to the clinic and secure larger financing syndicates for later clinical phases.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 9 of 30 portfolio companiesBiotech ×7Healthtech ×5Digital Health ×2Wellness & Fitness ×2Consumer ×1Deep Tech ×1Hardware ×1Longevity ×1
HQs:Spain×4United States×1
Investments · 30 tracked
founders shown can be your intro pathAbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.
BiotechHealthtech
Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)Carole Guillonneau(Co-founder & Head of Research)François-Xavier Hubert(Co-founder, Past President & Board Member)
Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs.
BiotechHealthtechSan Sebastián, ES
Asis Palazon(CEO/CSO & Founder)
aptaTargets is a clinical-stage biopharmaceutical company developing therapeutic aptamers for acute indications where inflammation causes damage, such as ischemic stroke, intracerebral hemorrhage, myocardial infarction, and multiple sclerosis.
BiotechHealthtechMadrid, ES
CIRCE Scientific develops patented ingredient synergies and formulations focused on cellular and systemic resilience, working with clients to co-create products for supplements, functional foods, cosmetics, and animal care.
BiotechLongevityWellness & Fitness
Development of point-of-care diagnostic testing systems.
Biopharmaceutical focused on developing therapeutic aptamers.
Predicting bone metastasis to improve cancer patients' quality of life.
Experimental screenings to find new polymorphs and co-crystals of active pharmaceutical ingredients.
Unlocking intra-cellular drug targets.
Novel in vitro diagnostic biomarker for the early detection of cardiac ischemia.
Next-generation immune cell engagers for cancer.
A novel mitochondrial-targeted therapy for neurodegenerative diseases.
Safer and more effective treatments for cancer patients.
Thymus-based therapies for immune-mediated diseases.
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers.
BiotechHealthtech
Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections.
ConsumerHealthtechWellness & Fitness
Biotech project supported by Caixa Capital Risc since its inception.
Oncology-focused company whose clinical assets moved to Boehringer Ingelheim and AstraZeneca.
Clinical assets for cancer treatment.
A new approach to calcification disorders.
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
BiotechPhiladelphia, US
Philip Ball(Executive Officer, Director)Damia Tormo Carulla(Director)Justin Vogel(Executive Officer, Director)Francisco Leon(Executive Officer, Director)Robert Goldstein(Director)
BoardPablo Cironi(Director)
Portfolio news
latest coverage across their companiesTolerance Bio · intelligence360.news · Jul 28, 2026
Frequently asked questions
- What stage does Criteria Bio Ventures invest at?
- Criteria Bio Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Criteria Bio Ventures focus on?
- Criteria Bio Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Criteria Bio Ventures located?
- Criteria Bio Ventures is headquartered in Barcelona, ES.
- Does Criteria Bio Ventures lead rounds?
- Yes, Criteria Bio Ventures leads investment rounds.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.